JAMA Network Home
Sign In
Research Letter

Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval

JAMA Internal Medicine 10.1001/jamainternmed.2025.6107

November 24, 2025 at 11:00 AM EST

Read the full article

This cross-sectional study assesses whether the characteristics of people who spoke at US Food and Drug Administration Human Drug Advisory Committee meetings on new drug approvals were associated with recommendations for drug approval.

Corresponding Author: Leah Z. Rand, DPhil, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, 1620 Tremont St, Ste 3030, Boston, MA 02120 (lzrand@bwh.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.6107?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=112425

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks